Chief Medical Officer

Executives at Mirum Pharmaceuticals Sell Shares

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals price target raised by $24 at JPMorgan, here's why

Transcript : Mirum Pharmaceuticals, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-08-2025 08

Associate Director, Marketing Thought Leader Liaison

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. The Thought Leader Liaison (TLL) serves as a key strategic partner between Mirum and the healthcare community, focusing on cultivating relationships with key opinion leaders and ensuring aligned engagement with external experts to enhance awareness and education.

Sign up with Google

Sign in with Google